loader
Please Wait
Applying Filters...

Information, Expiry & Status of FDA Orange Book Patents covering Ibrutinib

Menu
$ API Ref.Price (USD/KG) : 6,763Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 732PHARMACYCLICS LLC

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Luxepack
Not Confirmed

IBRUTINIB

US Patent Number : 9125889

Drug Substance Claim :

Drug Product Claim :

Application Number : 205552

Patent Use Code : U-1745

Delist Requested :

Patent Use Description : FOR THE TREATMENT OF P...

Patent Expiration Date : 2031-06-03

Abbvie company banner

02

arrow
Luxepack
Not Confirmed

IBRUTINIB

US Patent Number : 8999999

Drug Substance Claim :

Drug Product Claim :

Application Number : 205552

Patent Use Code : U-1684

Delist Requested :

Patent Use Description : TREATMENT OF CHRONIC L...

Patent Expiration Date : 2031-06-03

Abbvie company banner

03

arrow
Luxepack
Not Confirmed

IBRUTINIB

US Patent Number : 9540382

Drug Substance Claim :

Drug Product Claim :

Application Number : 205552

Patent Use Code : U-1947

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-08-18

Abbvie company banner

04

arrow
Luxepack
Not Confirmed

IBRUTINIB

US Patent Number : 8476284

Drug Substance Claim :

Drug Product Claim :

Application Number : 205552

Patent Use Code : U-1650

Delist Requested :

Patent Use Description : TREATMENT OF WALDENSTR...

Patent Expiration Date : 2026-12-28

Abbvie company banner

05

arrow
Luxepack
Not Confirmed

IBRUTINIB

US Patent Number : 8497277

Drug Substance Claim :

Drug Product Claim :

Application Number : 205552

Patent Use Code : U-1491

Delist Requested :

Patent Use Description : TREATMENT OF CHRONIC L...

Patent Expiration Date : 2026-12-28

Abbvie company banner

06

arrow
Luxepack
Not Confirmed

IBRUTINIB

US Patent Number : 8497277

Drug Substance Claim :

Drug Product Claim :

Application Number : 205552

Patent Use Code : U-1456

Delist Requested :

Patent Use Description : TREATMENT OF MANTLE CE...

Patent Expiration Date : 2026-12-28

Abbvie company banner

07

arrow
Luxepack
Not Confirmed

IBRUTINIB

US Patent Number : 8497277

Drug Substance Claim :

Drug Product Claim :

Application Number : 205552

Patent Use Code : U-1947

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-12-28

Abbvie company banner

08

arrow
Luxepack
Not Confirmed

IBRUTINIB

US Patent Number : 8497277

Drug Substance Claim :

Drug Product Claim :

Application Number : 205552

Patent Use Code : U-1946

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-12-28

Abbvie company banner

09

arrow
Luxepack
Not Confirmed

IBRUTINIB

US Patent Number : 8476284

Drug Substance Claim :

Drug Product Claim :

Application Number : 205552

Patent Use Code : U-1456

Delist Requested :

Patent Use Description : TREATMENT OF MANTLE CE...

Patent Expiration Date : 2026-12-28

Abbvie company banner

10

arrow
Luxepack
Not Confirmed

IBRUTINIB

US Patent Number : 8952015

Drug Substance Claim :

Drug Product Claim :

Application Number : 205552

Patent Use Code : U-1650

Delist Requested :

Patent Use Description : TREATMENT OF WALDENSTR...

Patent Expiration Date : 2026-12-28

Abbvie company banner